REBORN

The REBORN ambition is to provide a multifunctional, smart cardiac patch that, when translated to the clinic, is expected to significantly prevent heart failure in patients surviving an acute myocardial infarction (MI), reducing mortality and enhancing their quality of life.

THE CONSORTIUM

 

Politecnico di Torino, Italy

Universidade de Coimbra, Portugal

Scuola Superiore Sant’Anna, Italy

University of Newcastle Upon Tyne, UK

Universidade do Porto, Portugal

I3S – Instituto de Investigacao e Inovacao em Saude da Universidade do Porto, Portugal

Bioinicia SL, Spain

Santorini Scientific Ltd, UK

Regemat 3D Ltd, Spain

Corcym srl, Italy

Cellogic Gmbh, Germany

BeWarrant, Belgium